Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

3
results for

"Jun Lee"

Article category

Keywords

Publication year

"Jun Lee"

Original Article

Steatotic liver disease

Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study
Jaejun Lee, Taeyun Kim, Hyun Yang, Si Hyun Bae
Clin Mol Hepatol 2022;28(2):196-206.
Published online January 13, 2022
DOI: https://doi.org/10.3350/cmh.2021.0371
Background/Aims
Non-alcoholic fatty liver disease (NAFLD) has become a major concern in Korea since its emergence as a dominant cause of chronic liver disease. However, no study has explored its prevalence in adults under 30 years of age. Therefore, we performed a cross-sectional study to investigate the prevalence of NAFLD in Korean men in their early 20s.
Methods
We collected data of 596,359 Korean soldiers who participated in a health examination between January 2015 and July 2021. A total of 571,872 individuals were analyzed after excluding those with missing data and hepatitis B antigen positivity. Hepatic steatosis was determined using the hepatic steatosis index (HSI). Participants with HSI >36 were considered to have NAFLD.
Results
All participants were men, and the mean age was 20.9±1.3 years. Of the 571,872 participants screened, 77,020 (13.47%) were classified as having NAFLD. The prevalence of NAFLD consistently increased from 2015 to 2021 (10.66% vs. 16.44%, P<0.001). Increases from 2015 to 2021 were also noted in the prevalence of hypercholesterolemia, hyperglycemia, and hypertension (P<0.001 for all). The mean body mass index also increased from 23.3±3.0 kg/m2 to 23.9±3.1 kg/m2 between 2015 and 2021 (P<0.001).
Conclusions
The prevalence of NAFLD and of other metabolic dysfunctions in Korean men in their early 20s increased from 2015 to 2021.

Citations

Citations to this article as recorded by  Crossref logo
  • Appendicular skeletal muscle mass is associated with metabolic dysfunction-associated steatotic liver disease severity in young men: a cross-sectional and longitudinal study
    Jaejun Lee, Jinson So, Chang In Han, Hyun Yang, Pil Soo Sung, Si Hyun Bae, Do Seon Song
    Hepatology International.2025; 19(1): 181.     CrossRef
  • Differential Exercise Requirements for Nonalcoholic Fatty Liver Disease Resolution Across Age Groups: A Longitudinal Study of Korean Military Officers
    Jaejun Lee, Dong Yeup Lee, Jae Hyeop Jung, Eunkyoung Bae, Jeong A. Yu, Hyun Yang
    Journal of Physical Activity and Health.2025; 22(3): 323.     CrossRef
  • Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young Adults
    Jaejun Lee, Chang In Han, Dong Yeup Lee, Pil Soo Sung, Si Hyun Bae, Hyun Yang
    Gut and Liver.2025; 19(1): 116.     CrossRef
  • A Literature Review of Glutathione Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Liver Disease
    Michelle Thuy Nguyen, Andrew Lian, Frederick Timothy Guilford, Vishwanath Venketaraman
    Biomedicines.2025; 13(3): 644.     CrossRef
  • Effect of treadmill walking on cardiometabolic risk factors and liver function markers in older adults with MASLD: a randomized controlled trial
    Jiyoun Kim, Sungju Lee, Yong-Seok Jee
    BMC Sports Science, Medicine and Rehabilitation.2025;[Epub]     CrossRef
  • Association Between Nonalcoholic Fatty Liver Disease and Risk of Early-onset Colorectal Cancer
    Seulji Kim, Jin-Hyung Jung, Kyungdo Han, Seong-Joon Koh, Jong Pil Im, Byeong Gwan Kim, Joo Sung Kim, Hyun Jung Lee
    Clinical Gastroenterology and Hepatology.2025; 23(13): 2550.     CrossRef
  • Prevalence of Non-alcoholic Fatty Liver Disease in Iran: A Systematic Review and Meta-analysis
    Seidamir P. Tabaeian, Aziz Rezapour, Samad Azari, Mariano Martini, Maryam Saran, Meysam Behzadifar, Saeed Shahabi, Abdollah Sayyad, Ali Tahernejad, N.L. Bragazzi, S.J. Ehsanzadeh, Masoud Behzadifar
    Journal of Clinical and Experimental Hepatology.2024; 14(1): 101209.     CrossRef
  • Impact of Overseas Deployment on Fatty Liver and Metabolic Diseases Among Korean Soldiers
    Chang In Han, Jaejun Lee
    Military Medicine.2024; 189(7-8): e1621.     CrossRef
  • Impact of Korean Military Service on the Prevalence of Steatotic Liver Disease: A Longitudinal Study of Pre-enlistment and In-Service Health Check-Ups
    Jaejun Lee, Jae Hyeop Jung, Sung Jun Choi, Beomman Ha, Hyun Yang, Pil Soo Sung, Si Hyun Bae, Jeong-A Yu
    Gut and Liver.2024; 18(5): 888.     CrossRef
  • Serum uric acid and nonalcoholic fatty liver disease
    Jia Fan, Dongxu Wang
    Frontiers in Endocrinology.2024;[Epub]     CrossRef
  • Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease
    Ho Soo Chun, Minjong Lee, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong‐Ho Lee, Ji‐Hye Kim, Seung Up Kim
    Liver International.2023; 43(3): 608.     CrossRef
  • Global incidence and prevalence of nonalcoholic fatty liver disease
    Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Eunice Tan, Mark D. Muthiah
    Clinical and Molecular Hepatology.2023; 29(Suppl): S32.     CrossRef
  • Preventive effect of empagliflozin and ezetimibe on hepatic steatosis in adults and murine models
    Dong Yun Kim, Kyu Sik Chung, Jun Yong Park, Heon Yung Gee
    Biomedicine & Pharmacotherapy.2023; 161: 114445.     CrossRef
  • Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
    Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra
    Clinical and Molecular Hepatology.2023; 29(Suppl): S286.     CrossRef
  • Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
    Yi-wen Shi, Jian-Gao Fan
    Clinical and Molecular Hepatology.2023; 29(Suppl): S228.     CrossRef
  • Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management
    Anja Geerts, Sander Lefere
    Clinical and Molecular Hepatology.2023; 29(Suppl): S276.     CrossRef
  • The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
    Hyunwoo Oh, Won Sohn, Yong Kyun Cho
    Clinical and Molecular Hepatology.2023; 29(Suppl): S261.     CrossRef
  • Fatty Liver & Diabetes Statistics in Korea: Nationwide Data 2009 to 2017
    Eugene Han, Kyung-Do Han, Yong-ho Lee, Kyung-Soo Kim, Sangmo Hong, Jung Hwan Park, Cheol-Young Park
    Diabetes & Metabolism Journal.2023; 47(3): 347.     CrossRef
  • Low‐quality muscle mass rather than normal‐quality muscle mass determines fibrosis progression in biopsy‐proven NAFLD
    Yun Kyu Lee, Bo Kyung Koo, Sae Kyung Joo, Dong Hyeon Lee, Heejoon Jang, Jee Won Chai, Myoung Seok Lee, Si Won Jang, Young Ho So, Jeong Hwan Park, Mee Soo Chang, Won Kim
    Alimentary Pharmacology & Therapeutics.2023; 58(3): 322.     CrossRef
  • Analysis of risk factors related to nonalcoholic fatty liver disease: a retrospective study based on 31,718 adult Chinese individuals
    Ganggang Wang, Xiaowei Shen, Yicun Wang, Huanhua Lu, Hua He, Xiaoliang Wang
    Frontiers in Medicine.2023;[Epub]     CrossRef
  • A survey on the awareness, current management, and barriers for non-alcoholic fatty liver disease among the general Korean population
    Jun-Hyuk Lee, Jang Han Jung, Huiyul Park, Joo Hyun Oh, Sang Bong Ahn, Eileen Laurel Yoon, Dae Won Jun
    Scientific Reports.2023;[Epub]     CrossRef
  • Muscle Mass Adjusted for Body Weight Is Associated with Significant Liver Fibrosis in Young Adults with Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Korean Military Hospital
    Jaejun Lee, Seongjoo Na, Taeyun Kim, Seong-Woo Lee, Myoung Jung Kim, Chang In Han, Si Hyun Bae
    Journal of Obesity & Metabolic Syndrome.2023; 32(3): 279.     CrossRef
  • Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
    Soon Sun Kim, Jae Youn Cheong
    Clinical and Molecular Hepatology.2022; 28(4): 802.     CrossRef
  • 10,537 View
  • 233 Download
  • 23 Web of Science
  • Crossref

Letter to the Editor

Liver fibrosis, cirrhosis, and portal hypertension

Clinical characteristics of portal hypertension complicated by gastroesophageal varices in patients with myeloproliferative neoplasms
Jaejun Lee, Pil Soo Sung, Ki-Seong Eom, Hyun Yang, Soon Kyu Lee, Aung Hlaing Bwa, Angelo Lozada, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
Clin Mol Hepatol 2020;26(1):78-82.
Published online November 26, 2019
DOI: https://doi.org/10.3350/cmh.2019.0078

Citations

Citations to this article as recorded by  Crossref logo
  • Navigating ‘grey areas’ and challenges during evaluation of transplant eligibility in specific myelofibrosis populations: a perspective on behalf of the Chronic Malignancies Working Party of the EBMT
    Nicola Polverelli, Juan Carlos Hernández-Boluda, Nico Gagelmann, Carmelo Gurnari, Michele Malagola, Fernando Barroso Duarte, Vaneuza A. M. Funke, Caterina Zerbi, Donal P. McLornan
    Bone Marrow Transplantation.2025; 60(1): 10.     CrossRef
  • Role of Portosystemic Shunt and Portal Vein Stent in Managing Portal Hypertension Due to Hematological Diseases
    Ji Hoon Kim, Suho Kim, Hee-Chul Nam, Chang Wook Kim, Jae-Sung Yoo, Ji Won Han, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Ho-Jong Chun, Sung-Eun Lee, Jung-Suk Oh, Pil Soo Sung
    Cureus.2024;[Epub]     CrossRef
  • The Value of Follow‐Up Liver Stiffness Changes Measured by Virtual Touch Quantification Elastography for Predicting Recurrence of Gastroesophageal Varices after Endoscopic Injection Sclerotherapy on Cirrhotic Patients
    Yayang Duan, Jinfei Zhang, Min Fan, Derun Kong, Chaoxue Zhang, Jose Celso Ardengh
    Gastroenterology Research and Practice.2024;[Epub]     CrossRef
  • Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR‐ABL negative myeloproliferative neoplasms
    Marta Davidson, Florence Wong, Mostafa Atri, Hassan Sibai, Dawn Maze, Verna Cheung, Jeannie Callum, Eshetu G. Atenafu, Vikas Gupta
    American Journal of Hematology.2023;[Epub]     CrossRef
  • Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis
    Jacinta Perram, David M. Ross, Donal McLornan, Krisstina Gowin, Nicolas Kröger, Vikas Gupta, Clinton Lewis, Nico Gagelmann, Nada Hamad
    American Journal of Hematology.2022; 97(11): 1464.     CrossRef
  • 9,486 View
  • 187 Download
  • 5 Web of Science
  • Crossref
Original Article

Viral hepatitis

Comparison and analysis of the prevalence of hepatitis C virus infection by region in the Republic of Korea during 2005-2012
Hae-Sook Shon, Hwa Young Choi, Jang Rak Kim, So Yeon Ryu, Youn-Jae Lee, Myeong Jin Lee, Hyun Ju Min, Jun Lee, Yeong Jun Song, Moran Ki
Clin Mol Hepatol 2015;21(3):249-256.
Published online September 30, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.3.249
Background/Aims

This study compared the prevalence of hepatitis C virus (HCV) infection in the Republic of Korea and estimated the high-risk regions and towns.

Methods

National Health Insurance Service data for 8 years from 2005 to 2012 were used. The subjects of the study had visited medical facilities and been diagnosed with or received treatment for acute or chronic HCV as a primary or secondary disease according to ICD-10 codes of B17.1 or B18.2, respectively. Any patient who received treatment for the same disease multiple times during 1 year was counted as one patient in that year. To correct for the effect of the age structure of the population by year and region, the age-adjusted prevalence was calculated using the direct method based on the registered population in 2010.

Results

The overall prevalence of HCV infection among Korean adults (>20 years old) increased from 0.14% in 2005 to 0.18% in 2012. The sex-, age-, and region-adjusted prevalence in 2012 was 0.18%. The prevalence was highest in Busan, Jeonnam, and Gyeongnam, and there were towns with noticeably higher prevalences within these regions: Jindo (0.97%) in Jeonnam, Namhae (0.90%) in Gyeongnam, and Seo-gu (0.86%) in Busan.

Conclusions

The prevalence of HCV infection differs by regions as well as towns in the Republic of Korea, and is highest in Busan, Jeonnam, and Gyeongnam. The reasons for the high prevalence in these specific regions should be identified, since this could help prevent HCV infections in the future. In addition, active surveillance and treatment policies should be introduced to stop any further spread of infection in these high-prevalence regions.

Citations

Citations to this article as recorded by  Crossref logo
  • Economic evaluation of mass screening as a strategy for hepatitis C virus elimination in South Korea
    Hwa Young Choi, Kyung-Ah Kim, Bo Young Park, Bo Youl Choi, Moran Ki
    Journal of Infection and Public Health.2025; 18(3): 102662.     CrossRef
  • Insights into the spatial epidemiology of hepatitis C infection: systematic synthesis of area-level determinants and spatiotemporal analyses
    Jacob Mugoya Gizamba, Brian Karl Finch, Siqin Wang, Jeffrey D. Klausner
    BMC Public Health.2025;[Epub]     CrossRef
  • Temporal and geospatial patterns of hepatitis C virus prevalence: a longitudinal examination using national health insurance service data in the Republic of Korea (2005–2022)
    Hwa Young Choi, Moran Ki
    BMC Public Health.2025;[Epub]     CrossRef
  • Comorbidities and the use of comedications among patients with chronic hepatitis C in Korea: A nationwide cross-sectional study
    Kyung Min Kwon, Jae-Jun Shim, Gi-Ae Kim, Bo Ok Kim, Helin Han, Hyun Jung Ahn
    The Korean Journal of Internal Medicine.2023; 38(3): 338.     CrossRef
  • Clinical and histopathological analyses of kidney biopsies in a single center for 7 years
    Seunghye Lee, Sehyun Jung, Mi-Ji Kim, Jong Sil Lee, Ha Nee Jang, Se-Ho Chang, Hyun-Jung Kim
    Medicine.2022; 101(29): e29695.     CrossRef
  • The predictors of sustained virological response with sofosbuvir and ribavirin in patients with chronic hepatitis C genotype 2
    Sung Yong Han, Hyun Young Woo, Jeong Heo, Sang Gyu Park, Sung Ik Pyeon, Young Joo Park, Dong Uk Kim, Gwang Ha Kim, Hyung Hoi Kim, Geun Am Song, Mong Cho
    The Korean Journal of Internal Medicine.2021; 36(3): 544.     CrossRef
  • The changing epidemiology of liver diseases in the Asia–Pacific region
    Martin C. S. Wong, Jason L. W. Huang, Jacob George, Junjie Huang, Colette Leung, Mohammed Eslam, Henry L. Y. Chan, Siew C. Ng
    Nature Reviews Gastroenterology & Hepatology.2019; 16(1): 57.     CrossRef
  • Apolipoprotein E Genotype and Expression Correlated with Hepatitis C Virus Genotype and Infection
    Gyu-Nam Park, Hyun-Jung Jo, Hye-Ran Kim, Min-Ju Kim, Kyung-A Shin, Seung-Bok Hong, Kyung-Soo Chang
    Journal of Bacteriology and Virology.2019; 49(1): 27.     CrossRef
  • Incidence and Overall Survival of Biliary Tract Cancers in South Korea from 2006 to 2015: Using the National Health Information Database
    Byung-Woo Kim, Chang-Mo Oh, Hwa Young Choi, Joong-Won Park, Hyunsoon Cho, Moran Ki
    Gut and Liver.2019; 13(1): 104.     CrossRef
  • Why is Life Expectancy in Busan Shorter than in Seoul? Age and Cause-Specific Contributions to the Difference in Life Expectancy between Two Cities
    Young-Ho Khang, Jinwook Bahk
    Yonsei Medical Journal.2019; 60(7): 687.     CrossRef
  • Transmission routes of hepatitis C virus in Rahim Yar Khan: hospital based study
    M. Ali Malik, M.A. Rehman, Nadia Usman
    International Journal of Biosciences (IJB).2019; : 418.     CrossRef
  • Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones
    Hyun Jung Kim, Tae Uk Kang, Heather Swan, Min Ji Kang, Nayoung Kim, Hyeong Sik Ahn, Seon Mee Park
    Digestive Diseases and Sciences.2018; 63(12): 3465.     CrossRef
  • Understanding the complications of anti‐tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease
    Jae Hee Cheon
    Journal of Gastroenterology and Hepatology.2017; 32(4): 769.     CrossRef
  • Current status of hepatitis C virus infection and countermeasures in South Korea
    Sook-Hyang Jeong, Eun Sun Jang, Hwa Young Choi, Kyung-Ah Kim, Wankyo Chung, Moran Ki
    Epidemiology and Health.2017; 39: e2017017.     CrossRef
  • Efficacy and safety of sofosbuvir-based regimens for treatment in chronic hepatitis C genotype 1 patients with moderately impaired renal function
    Hyun Phil Shin, Ji-Ae Park, Blaire Burman, Richard A. Kozarek, Asma Siddique
    Clinical and Molecular Hepatology.2017; 23(4): 316.     CrossRef
  • Increased survival in hepatitis c patients who underwent living donor liver transplant: a case-control study with propensity score matching
    Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, Choon Hyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee
    Annals of Surgical Treatment and Research.2017; 93(6): 293.     CrossRef
  • 12,261 View
  • 89 Download
  • 16 Web of Science
  • Crossref